OTC

Strength

2; 10; 5 mg/10mL; mg/10mL; mg/10mL

NDC

70677012101

Classification

Generic

Dosage Form

LIQUID

Route

ORAL

Last Updated

5/17/2023

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

10/30/2020

Pharmacological Classes

Adrenergic alpha1-Agonists
Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists
alpha-1 Adrenergic Agonist

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

N/A

All

+1.2%